"Neoplasm Grading" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.
| Descriptor ID |
D060787
|
| MeSH Number(s) |
E01.789.612
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Grading".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Grading".
This graph shows the total number of publications written about "Neoplasm Grading" by people in this website by year, and whether "Neoplasm Grading" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 5 | 5 |
| 2012 | 1 | 12 | 13 |
| 2013 | 2 | 20 | 22 |
| 2014 | 0 | 15 | 15 |
| 2015 | 1 | 21 | 22 |
| 2016 | 0 | 9 | 9 |
| 2017 | 0 | 14 | 14 |
| 2018 | 0 | 17 | 17 |
| 2019 | 1 | 18 | 19 |
| 2020 | 1 | 12 | 13 |
| 2021 | 1 | 10 | 11 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 1 | 2 |
| 2024 | 0 | 2 | 2 |
| 2025 | 0 | 9 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Grading" by people in Profiles.
-
Clinicopathologic and Molecular Characteristics of High-Grade Appendiceal Mucinous Neoplasms. Ann Surg Oncol. 2026 Mar; 33(3):2376-2387.
-
Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples. Eur Urol Oncol. 2025 Dec; 8(6):1629-1638.
-
High-grade glioma with pleomorphic and pseudopapillary features: a single-institution series of three cases. Acta Neuropathol Commun. 2025 Aug 18; 13(1):176.
-
Perfusion Showdown: Comparison of Multiple MRI Perfusion Techniques in the Grading of Pediatric Brain Tumors. AJNR Am J Neuroradiol. 2025 Jul 01; 46(7):1464-1470.
-
NF2 loss-of-function and hypoxia drive radiation resistance in grade 2 meningiomas. J Natl Cancer Inst. 2025 Jun 01; 117(6):1175-1187.
-
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group study. Neuro Oncol. 2025 May 15; 27(4):1092-1101.
-
Effective targeting of PDGFRA-altered high-grade glioma with avapritinib. Cancer Cell. 2025 Apr 14; 43(4):740-756.e8.
-
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Gu?rin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing Therapies. Eur Urol Focus. 2025 May; 11(3):448-455.
-
Molecular Dynamics of Breast Cancer Subtypes: The Role of FAM83H-AS1 Long Non-coding RNA in Breast Cancer Metastasis. Breast Cancer Res Treat. 2025 Apr; 210(3):645-659.
-
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors. J Clin Oncol. 2024 Aug 10; 42(23):2769-2779.